Email updates

Keep up to date with the latest news and content from BMC Biotechnology and BioMed Central.

Open Access Research article

Characterization of a modified ROCK2 protein that allows use of N6-ATP analogs for the identification of novel substrates

Amber L Couzens12, R Montgomery Gill1 and Michael P Scheid1*

Author Affiliations

1 Department of Biology, York University, 4700 Keele Street, Toronto, ON M3J1P3, Canada

2 Current Address: Centre for Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada

For all author emails, please log on.

BMC Biotechnology 2014, 14:2  doi:10.1186/1472-6750-14-2

Published: 9 January 2014

Abstract

Background

The Rho-associated coiled-coil kinase-2 (ROCK2) is an important signaling transducer in the transmission of extracellular signals effecting organization of the actin cytoskeleton. ROCK2 has been implicated in numerous pathologies and the current focus is on understanding the molecular events that couple ROCK2 activity to biological function. To aid in the search for new ROCK2 substrates, we have developed an analog-sensitive (AS) ROCK2 protein that allows the use of selective ATP analogs that are not efficiently utilized by other protein kinases.

Results

The analog sensitive protein, M160A ROCK2, was highly active and could phosphorylate proteins from a cellular homogenate with γ32P-N6 (benzyl)ATP. We show the utility of this approach by identifying a putative ROCK2 substrate, elongation initiation factor-1-α1. We further show that the major site of ROCK2 phosphorylation of EIF1α1 is Thr432.

Conclusions

Our work demonstrates that AS-ROCK2 could be useful in a systematic proteomic approach for identifying novel ROCK2 substrates.

Keywords:
ROCK2; Protein kinase; Chemical engineering; Cell signaling